BRD2 and congenital hypogonadotropic hypogonadism: Treatment with gonadotropins like hCG and FSH promotes testicular growth and spermatogenesis in adolescent boys with congenital hypogonadotropic hypogonadism (CHH), unlike testosterone therapy.